{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:34:27Z","timestamp":1771058067019,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","award":["No number"],"award-info":[{"award-number":["No number"]}],"id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s12020-018-1738-6","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T16:41:17Z","timestamp":1536252077000},"page":"519-527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5903-3355","authenticated-orcid":false,"given":"Ulla","family":"Feldt-Rasmussen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Klose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,6]]},"reference":[{"key":"1738_CR1","first-page":"560","volume-title":"Werners & Ingbar's The thyroid. A clinical and fundamental text","author":"L Persani","year":"2013","unstructured":"L. Persani, P. Beck-Peccoz Central Hypothyroidism. In: L. Braverman, D. Cooper, (eds.) Werners & Ingbar's The thyroid. A clinical and fundamental text. 10th ed. Philadelphia: Wolters Kluwer, Lippincott Williams & Wilkins, 2013; 560\u2013568.","edition":"10th ed."},{"key":"1738_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12020-016-1047-x","volume":"54","author":"U Feldt-Rasmussen","year":"2016","unstructured":"U. Feldt-Rasmussen, M. Klose, Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients. Endocrine 54, 15\u201323 (2016)","journal-title":"Endocrine"},{"key":"1738_CR3","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1210\/jc.2012-1616","volume":"97","author":"L Persani","year":"2012","unstructured":"L. Persani, Clinical review: central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J. Clin. Endocrinol. Metab. 97, 3068\u20133078 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1738_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/105072503321086962","volume":"13","author":"Z Baloch","year":"2003","unstructured":"Z. Baloch, P. Carayon, B. Conte-Devolx, L.M. Demers, U. Feldt-Rasmussen, J.F. Henry, V.A. LiVosli, P. Niccoli-Sire, R. John, J. Ruf, P.P. Smyth, C.A. Spencer, J.R. Stockigt, Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13, 3\u2013126 (2003)","journal-title":"Thyroid"},{"key":"1738_CR5","unstructured":"J.R. Stockigt, in Endotext, https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK285558\/ (2011). Accessed February 2018"},{"key":"1738_CR6","first-page":"771","volume":"82","author":"H Zulewski","year":"1997","unstructured":"H. Zulewski, B. Muller, P. Exer, A.R. Miserez, J.J. Staub, Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J. Clin. Endocrinol. Metab. 82, 771\u2013776 (1997)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1738_CR7","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/BF02599546","volume":"4","author":"MS Seshadri","year":"1989","unstructured":"M.S. Seshadri, B.U. Samuel, A.S. Kanagasabapathy, A.M. Cherian, Clinical scoring system for hypothyroidism: is it useful? J. Gen. Intern. Med. 4, 490\u2013492 (1989)","journal-title":"J. Gen. Intern. Med."},{"key":"1738_CR8","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1089\/thy.2014.0201","volume":"24","author":"G Berghe Van den","year":"2014","unstructured":"G. Van den Berghe, Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid 24, 1456\u20131465 (2014)","journal-title":"Thyroid"},{"key":"1738_CR9","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/bmj.321.7271.1275","volume":"321","author":"A Waise","year":"2000","unstructured":"A. Waise, P.E. Belchetz, Lesson of the week: unsuspected central hypothyroidism. BMJ 321, 1275\u20131277 (2000)","journal-title":"BMJ"},{"key":"1738_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrendo.2017.47","volume":"13","author":"P Beck-Peccoz","year":"2017","unstructured":"P. Beck-Peccoz, G. Rodari, C. Giavoli, A. Lania, Central hypothyroidism - a neglected thyroid disorder. Nat. Rev. Endocrinol. 13, 588\u2013598 (2017)","journal-title":"Nat. Rev. Endocrinol."},{"key":"1738_CR11","doi-asserted-by":"crossref","unstructured":"S. Benvenga, M. Klose, R. Vita, U. Feldt-Rasmussen, Less known aspects of central hypothyroidism: part 1 - aquired etiologies. J. Clin. Transl. Endocrinol. (2018) (in press)","DOI":"10.1016\/j.jcte.2018.09.003"},{"key":"1738_CR12","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.2174\/092986707782360114","volume":"14","author":"U Feldt-Rasmussen","year":"2007","unstructured":"U. Feldt-Rasmussen, Interactions between growth hormone and the thyroid gland -- with special reference to biochemical diagnosis. Curr. Med. Chem. 14, 2783\u20132788 (2007)","journal-title":"Curr. Med. Chem."},{"key":"1738_CR13","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1530\/EJE-09-0319","volume":"161 Suppl 1","author":"H Filipsson","year":"2009","unstructured":"H. Filipsson, G. Johannsson, GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies. Eur. J. Endocrinol. 161 Suppl 1, S85\u2013S95 (2009)","journal-title":"Eur. J. Endocrinol."},{"key":"1738_CR14","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1210\/jc.2013-1610","volume":"98","author":"M Klose","year":"2013","unstructured":"M. Klose, D. Marina, M.L. Hartoft-Nielsen, O. Klefter, V. Gavan, L. Hilsted, A.K. Rasmussen, U. Feldt-Rasmussen, Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients. J. Clin. Endocrinol. Metab. 98, 3802\u20133810 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1738_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11102-011-0356-6","volume":"15","author":"NH Filipsson","year":"2012","unstructured":"N.H. Filipsson, U. Feldt-Rasmussen, I. Kourides, V. Popovic, M. Koltowska-Haggstrom, B. Jonsson, G. Johannsson, The metabolic consequences of thyroxine replacement in adult hypopituitary patients. Pituitary 15, 495\u2013504 (2012)","journal-title":"Pituitary"},{"issue":"5","key":"1738_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000491388","volume":"7","author":"Luca Persani","year":"2018","unstructured":"L. Persani, G. Brabant, D. Dattani, M. Bonomi, U. Feldt-Rasmussen, E. Fliers, A. Gruters, D. Maiter, N. Schoenmakers, A.S. Trotsenburg, 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism. Eur. Thyroid J. e-pub ahead of print. https:\/\/doi.org\/10.1159\/000491388 (2018)","journal-title":"European Thyroid Journal"},{"key":"1738_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11102-014-0559-8","volume":"18","author":"S Grunenwald","year":"2015","unstructured":"S. Grunenwald, P. Caron, Central hypothyroidism in adults: better understanding for better care. Pituitary 18, 169\u2013175 (2015)","journal-title":"Pituitary"},{"key":"1738_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1210\/jc.2002-020380","volume":"88","author":"M Schmiegelow","year":"2003","unstructured":"M. Schmiegelow, U. Feldt-Rasmussen, A.K. Rasmussen, H.S. Poulsen, J. Muller, A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor. J. Clin. Endocrinol. Metab. 88, 136\u2013140 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1738_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1365-2265.2001.01292.x","volume":"55","author":"A Lando","year":"2001","unstructured":"A. Lando, K. Holm, K. Nysom, A.K. Rasmussen, U. Feldt-Rasmussen, J.H. Petersen, J. Muller, Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation. Clin. Endocrinol. 55, 21\u201325 (2001)","journal-title":"Clin. Endocrinol."},{"key":"1738_CR20","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/pbc.25064","volume":"61","author":"A Saha","year":"2014","unstructured":"A. Saha, C.G. Salley, P. Saigal, L. Rolnitzky, J. Goldberg, S. Scott, R. Olshefski, J. Hukin, S.A. Sands, J. Finlay, S.L. Gardner, Late effects in survivors of childhood CNS tumors treated on head start I and II protocols. Pediatr. Blood Cancer 61, 1644\u20131652 (2014)","journal-title":"Pediatr. Blood Cancer"},{"key":"1738_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/cncr.11095","volume":"97","author":"JG Gurney","year":"2003","unstructured":"J.G. Gurney, N.S. Kadan-Lottick, R.J. Packer, J.P. Neglia, C.A. Sklar, J.A. Punyko, M. Stovall, Y. Yasui, H.S. Nicholson, S. Wolden, D.E. McNeil, A.C. Mertens, L.L. Robison, Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 97, 663\u2013673 (2003)","journal-title":"Cancer"},{"key":"1738_CR22","doi-asserted-by":"publisher","first-page":"R217","DOI":"10.1530\/EJE-16-0962","volume":"176","author":"A Garrahy","year":"2017","unstructured":"A. Garrahy, M. Sherlock, C.J. Thompson, Management of endocrine disease: neuroendocrine surveillance and management of neurosurgical patients. Eur. J. Endocrinol. 176, R217\u2013R233 (2017)","journal-title":"Eur. J. Endocrinol."},{"key":"1738_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrendo.2017.103","volume":"14","author":"M Klose","year":"2018","unstructured":"M. Klose, U. Feldt-Rasmussen, Chronic endocrine consequences of traumatic brain injury - what is the evidence? Nat. Rev. Endocrinol. 14, 57\u201362 (2018)","journal-title":"Nat. Rev. Endocrinol."},{"key":"1738_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1530\/EJE-09-1045","volume":"162","author":"S Roug","year":"2010","unstructured":"S. Roug, A.K. Rasmussen, M. Juhler, M. Kosteljanetz, L. Poulsgaard, H. Heeboll, H. Roed, U. Feldt-Rasmussen, Fractionated stereotactic radiotherapy in patients with acromegaly: an interim single-centre audit. Eur. J. Endocrinol. 162, 685\u2013694 (2010)","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"1738_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/0284186X.2016.1270466","volume":"56","author":"Arnar Astradsson","year":"2017","unstructured":"A. Astradsson, P. Munck Af Rosensch\u00f6ld, U. Feldt-Rasmussen, L. Poulsgaard, A.K. Wiencke, L. Ohlhues, S.A. Engelholm, H. Broholm, M.E. Hansen, M. Klose, H. Roed, M. Juhler, Visual outcome, endocrine function and tumor control after fractionated stereotactic radiation therapy of craniopharyngiomas in adults: findings in a prospective cohort. Acta Oncol. 56, 415\u2013421 (2017)","journal-title":"Acta Oncologica"},{"key":"1738_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0002-9343(86)90299-8","volume":"81","author":"PJ Snyder","year":"1986","unstructured":"P.J. Snyder, B.F. Fowble, N.J. Schatz, P.J. Savino, T.A. Gennarelli, Hypopituitarism following radiation therapy of pituitary adenomas. Am. J. Med. 81, 457\u2013462 (1986)","journal-title":"Am. J. Med."},{"key":"1738_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1056\/NEJM199301143280203","volume":"328","author":"LS Constine","year":"1993","unstructured":"L.S. Constine, P.D. Woolf, D. Cann, G. Mick, K. McCormick, R.F. Raubertas, P. Rubin, Hypothalamic-pituitary dysfunction after radiation for brain tumors. N. Engl. J. Med. 328, 87\u201394 (1993)","journal-title":"N. Engl. J. Med."},{"key":"1738_CR28","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/j.1365-2265.2012.04442.x","volume":"77","author":"N Mathioudakis","year":"2012","unstructured":"N. Mathioudakis, S. Thapa, G.S. Wand, R. Salvatori, ACTH-secreting pituitary microadenomas are associated with a higher prevalence of central hypothyroidism compared to other microadenoma types. Clin. Endocrinol. 77, 871\u2013876 (2012)","journal-title":"Clin. Endocrinol."},{"key":"1738_CR29","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1210\/jcem-62-6-1173","volume":"62","author":"BM Arafah","year":"1986","unstructured":"B.M. Arafah, Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J. Clin. Endocrinol. Metab. 62, 1173\u20131179 (1986)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1738_CR30","unstructured":"U. Feldt-Rasmussen, M. Klose, in Endotext, https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK425701\/ (2017). Accessed February 2018"},{"key":"1738_CR31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.beem.2009.08.003","volume":"23","author":"BR Haugen","year":"2009","unstructured":"B.R. Haugen, Drugs that suppress TSH or cause central hypothyroidism. Best. Pract. Res. Clin. Endocrinol. Metab. 23, 793\u2013800 (2009)","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"1738_CR32","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1056\/NEJM199904083401404","volume":"340","author":"SI Sherman","year":"1999","unstructured":"S.I. Sherman, J. Gopal, B.R. Haugen, A.C. Chiu, K. Whaley, P. Nowlakha, M. Duvic, Central hypothyroidism associated with retinoid X receptor-selective ligands. N. Engl. J. Med. 340, 1075\u20131079 (1999)","journal-title":"N. Engl. J. Med."},{"key":"1738_CR33","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1530\/EJE-13-0920","volume":"170","author":"J Graeppi-Dulac","year":"2014","unstructured":"J. Graeppi-Dulac, V. Vlaeminck-Guillem, M. Perier-Muzet, S. Dalle, J. Orgiazzi, Endocrine side-effects of anti-cancer drugs: The impact of retinoids on the thyroid axis. Eur. J. Endocrinol. 170, R253\u2013R262 (2014)","journal-title":"Eur. J. Endocrinol."},{"key":"1738_CR34","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/en.2009-1404","volume":"151","author":"MC Zatelli","year":"2010","unstructured":"M.C. Zatelli, E. Gentilin, F. Daffara, F. Tagliati, G. Reimondo, G. Carandina, M.R. Ambrosio, M. Terzolo, E.C. Degli Uberti, Therapeutic concentrations of mitotane (o,p\u2032-DDD) inhibit hyrotroph cell viability and TSH expression and secretion in a mouse cell line model. Endocrinology 151, 2453\u20132461 (2010)","journal-title":"Endocrinology"},{"key":"1738_CR35","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/cen.12868","volume":"84","author":"M Russo","year":"2015","unstructured":"M. Russo, C. Scollo, G. Pellegriti, O.R. Cotta, S. Squatrito, F. Frasca, S. Cannavo, D. Gullo, Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism. Clin. Endocrinol. 84, 614\u201319 (2015)","journal-title":"Clin. Endocrinol."},{"key":"1738_CR36","doi-asserted-by":"publisher","first-page":"R153","DOI":"10.1530\/EJE-13-0434","volume":"169","author":"F Torino","year":"2013","unstructured":"F. Torino, A. Barnabei, R.M. Paragliola, P. Marchetti, R. Salvatori, S.M. Corsello, Endocrine side-effects of anticancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. Eur. J. Endocrinol. 169, R153\u2013R164 (2013)","journal-title":"Eur. J. Endocrinol."},{"key":"1738_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1210\/jc.2013-2397","volume":"99","author":"M Klose","year":"2014","unstructured":"M. Klose, K. Stochholm, J. Janukonyte, C.L. Lehman, J. Frystyk, M. Andersen, P. Laurberg, J.S. Christiansen, U. Feldt-Rasmussen, Prevalence of posttraumatic growth hormone deficiency is highly dependent on the diagnostic set-up: results from The Danish National Study on Posttraumatic Hypopituitarism. J. Clin. Endocrinol. Metab. 99, 101\u2013110 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1738_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1530\/eje.0.1490091","volume":"149","author":"JA Romijn","year":"2003","unstructured":"J.A. Romijn, J.W. Smit, S.W. Lamberts, Intrinsic imperfections of endocrine replacement therapy. Eur. J. Endocrinol. 149, 91\u201397 (2003)","journal-title":"Eur. J. Endocrinol."},{"key":"1738_CR39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2006.02688.x","volume":"66","author":"A Agha","year":"2007","unstructured":"A. Agha, D. Walker, L. Perry, W.M. Drake, S.L. Chew, P.J. Jenkins, A.B. Grossman, J.P. Monson, Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin. Endocrinol. 66, 72\u201377 (2007)","journal-title":"Clin. Endocrinol."},{"key":"1738_CR40","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2265.1994.tb01826.x","volume":"41","author":"JO Jorgensen","year":"1994","unstructured":"J.O. Jorgensen, J. Moller, T. Laursen, H. Orskov, J.S. Christiansen, J. Weeke, Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin. Endocrinol. 41, 609\u2013614 (1994)","journal-title":"Clin. Endocrinol."},{"key":"1738_CR41","first-page":"63","volume":"38 Suppl 1","author":"JO Jorgensen","year":"1992","unstructured":"J.O. Jorgensen, J. Moller, N.E. Skakkebaek, J. Weeke, J.S. Christiansen, Thyroid function during growth hormone therapy. Horm. Res. 38 Suppl 1, 63\u201367 (1992)","journal-title":"Horm. Res."},{"key":"1738_CR42","first-page":"73","volume":"6","author":"P Laurberg","year":"1994","unstructured":"P. Laurberg, P.E. Jakobsen, H.C. Hoeck, P. Vestergaard, Growth hormone and thyroid function: is secondary thyroid failure underdiagnosed in growth hormone deficient patients? Thyroidology 6, 73\u201379 (1994)","journal-title":"Thyroidology"},{"key":"1738_CR43","first-page":"1727","volume":"85","author":"AA Toogood","year":"2000","unstructured":"A.A. Toogood, N.F. Taylor, S.M. Shalet, J.P. Monson, Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients. J. Clin. Endocrinol. Metab. 85, 1727\u20131730 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1738_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2265.2010.03815.x","volume":"74","author":"LA Behan","year":"2011","unstructured":"L.A. Behan, J.P. Monson, A. Agha, The interaction between growth hormone and the thyroid axis in hypopituitary patients. Clin. Endocrinol. 74, 281\u2013288 (2011)","journal-title":"Clin. Endocrinol."},{"key":"1738_CR45","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1365-2265.2006.02652.x","volume":"65","author":"C Schmid","year":"2006","unstructured":"C. Schmid, C. Zwimpfer, M. Brandle, P.A. Krayenbuhl, J. Zapf, P. Wiesli, Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism. Clin. Endocrinol. 65, 706\u2013711 (2006)","journal-title":"Clin. Endocrinol."},{"key":"1738_CR46","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1210\/jcem.85.3.6463","volume":"85","author":"JP Span","year":"2000","unstructured":"J.P. Span, G.F. Pieters, C.G. Sweep, A.R. Hermus, A.G. Smals, Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. J. Clin. Endocrinol. Metab. 85, 1121\u20131125 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1738_CR47","doi-asserted-by":"publisher","first-page":"E1191","DOI":"10.1152\/ajpendo.2001.281.6.E1191","volume":"281","author":"T Wolthers","year":"2001","unstructured":"T. Wolthers, D.M. Hoffman, A.G. Nugent, M.W. Duncan, M. Umpleby, K.K. Ho, Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. Am. J. Physiol. Endocrinol. Metab. 281, E1191\u2013E1196 (2001)","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1738_CR48","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1530\/eje.1.01898","volume":"152","author":"JJ Christiansen","year":"2005","unstructured":"J.J. Christiansen, S. Fisker, C.H. Gravholt, P. Bennett, B. Svenstrup, M. Andersen, U. Feldt-Rasmussen, J.S. Christiansen, J.O. Jorgensen, Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I. Eur. J. Endocrinol. 152, 719\u2013726 (2005)","journal-title":"Eur. J. Endocrinol."},{"key":"1738_CR49","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1210\/jcem-72-2-374","volume":"72","author":"AJ Weissberger","year":"1991","unstructured":"A.J. Weissberger, K.K. Ho, L. Lazarus, Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24 hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J. Clin. Endocrinol. Metab. 72, 374\u2013381 (1991)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1738_CR50","first-page":"1694","volume":"86","author":"JH Oliveira","year":"2001","unstructured":"J.H. Oliveira, L. Persani, P. Beck-Peccoz, J. Abucham, Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan\u2019s syndrome: characterization of TSH carbohydrate content and bioactivity. J. Clin. Endocrinol. Metab. 86, 1694\u20131699 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1738_CR51","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ecl.2017.04.002","volume":"46","author":"NH Esfandiari","year":"2017","unstructured":"N.H. Esfandiari, M. Papaleontiou, Biochemical testing in thyroid disorders. Endocrinol. Metab. Clin. North Am. 46, 631\u2013648 (2017)","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"1738_CR52","doi-asserted-by":"publisher","first-page":"300","DOI":"10.11613\/BM.2017.033","volume":"27","author":"LD Premawardhana","year":"2017","unstructured":"L.D. Premawardhana, Thyroid testing in acutely ill patients may be an expensive distraction. Biochem. Med. 27, 300\u2013307 (2017)","journal-title":"Biochem. Med."},{"key":"1738_CR53","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1055\/s-2007-978654","volume":"32","author":"S Benvenga","year":"2000","unstructured":"S. Benvenga, S. Squadrito, F. Saporito, A. Cimino, F. Arrigo, F. Trimarchi, Myxedema coma of both primary and secondary origin, with non-classic presentation and extremely elevated creatine kinase. Horm. Metab. Res. 32, 364\u2013366 (2000)","journal-title":"Horm. Metab. Res."},{"key":"1738_CR54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1507\/endocrj.K10E-329","volume":"58","author":"K Iida","year":"2011","unstructured":"K. Iida, Y. Hino, T. Ohara, K. Chihara, A case of myxedema coma caused by isolated thyrotropin stimulating hormone deficiency and Hashimoto\u2019s thyroiditis. Endocr. J. 58, 143\u2013148 (2011)","journal-title":"Endocr. J."},{"key":"1738_CR55","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1530\/acta.0.0950328","volume":"95","author":"U Feldt-Rasmussen","year":"1980","unstructured":"U. Feldt-Rasmussen, P.P. Hyltoft, O. Blaabjerg, M. Horder, Long-term variability in serum thyroglobulin and thyroid related hormones in healthy subjects. Acta Endocrinol. 95, 328\u2013334 (1980)","journal-title":"Acta Endocrinol."},{"key":"1738_CR56","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1210\/jcem.87.3.8165","volume":"87","author":"S Andersen","year":"2002","unstructured":"S. Andersen, K.M. Pedersen, N.H. Bruun, P. Laurberg, Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J. Clin. Endocrinol. Metab. 87, 1068\u20131072 (2002)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1738_CR57","doi-asserted-by":"publisher","first-page":"R255","DOI":"10.1530\/EJE-16-0193","volume":"175","author":"KJ Welsh","year":"2016","unstructured":"K.J. Welsh, S.J. Soldin, Diagnosis of endocrine disease: how reliable are free thyroid and total T3 hormone assays? Eur. J. Endocrinol. 175, R255\u2013R263 (2016)","journal-title":"Eur. J. Endocrinol."},{"key":"1738_CR58","first-page":"53","volume":"61","author":"ML Hartoft-Nielsen","year":"2004","unstructured":"M.L. Hartoft-Nielsen, M. Lange, A.K. Rasmussen, S. Scherer, T. Zimmermann-Belsing, U. Feldt-Rasmussen, Thyrotropin-releasing hormone stimulation test in patients with pituitary pathology. Horm. Res. 61, 53\u201357 (2004)","journal-title":"Horm. Res."},{"key":"1738_CR59","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/thy.2009.0311","volume":"20","author":"B Biondi","year":"2010","unstructured":"B. Biondi, D.S. Cooper, Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid 20, 135\u2013146 (2010)","journal-title":"Thyroid"},{"key":"1738_CR60","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1172\/JCI60047","volume":"122","author":"GA Brent","year":"2012","unstructured":"G.A. Brent, Mechanisms of thyroid hormone action. J. Clin. Invest. 122, 3035\u20133043 (2012)","journal-title":"J. Clin. Invest."},{"key":"1738_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00003.2011","volume":"92","author":"C Perez-Castro","year":"2012","unstructured":"C. Perez-Castro, U. Renner, M.R. Haedo, G.K. Stalla, E. Arzt, Cellular and molecular specificity of pituitary gland physiology. Physiol. Rev. 92, 1\u201338 (2012)","journal-title":"Physiol. Rev."},{"key":"1738_CR62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.beem.2017.03.003","volume":"31","author":"V Birzniece","year":"2017","unstructured":"V. Birzniece, K.K.Y. Ho, Sex steroids and the GH axis: Implications for the management of hypopituitarism. Best. Pract. Res. Clin. Endocrinol. Metab. 31, 59\u201369 (2017)","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"1738_CR63","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/thy.2014.0028","volume":"24","author":"J Jonklaas","year":"2014","unstructured":"J. Jonklaas, A.C. Bianco, A.J. Bauer, K.D. Burman, A.R. Cappola, F.S. Celi, D.S. Cooper, B.W. Kim, R.P. Peeters, M.S. Rosenthal, A.M. Sawka, Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid 24, 1670\u20131751 (2014)","journal-title":"Thyroid"},{"key":"1738_CR64","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fendo.2017.00321","volume":"8","author":"S Benvenga","year":"2017","unstructured":"S. Benvenga, G. Capodicasa, S. Perelli, l-Thyroxine in an oral liquid or softgel formulation ensures more normal serum levels of free T4 in patients with central hypothyroidism. Front Endocrinol. 8, 321 (2017)","journal-title":"Front Endocrinol."},{"key":"1738_CR65","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/MED.0000000000000003","volume":"20","author":"S Benvenga","year":"2013","unstructured":"S. Benvenga, When thyroid hormone replacement is ineffective? Curr. Opin. Endocrinol. Diabetes Obes. 20, 467\u2013477 (2013)","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"1738_CR66","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1210\/jc.2013-2409","volume":"99","author":"MA Garmendia","year":"2014","unstructured":"M.A. Garmendia, P.S. Santos, F. Guillen-Grima, J.C. Galofre, The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J. Clin. Endocrinol. Metab. 99, 923\u2013931 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1738_CR67","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","volume":"55","author":"M Regal","year":"2001","unstructured":"M. Regal, C. Paramo, S.M. Sierra, R.V. Garcia-Mayor, Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin. Endocrinol. 55, 735\u2013740 (2001)","journal-title":"Clin. Endocrinol."},{"key":"1738_CR68","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1258\/acb.2007.007100","volume":"45","author":"D Preiss","year":"2008","unstructured":"D. Preiss, L. Todd, M. Panarelli, Diagnosing unsuspected hypopituitarism in adults from suggestive thyroid function test results. Ann. Clin. Biochem. 45, 70\u201375 (2008)","journal-title":"Ann. Clin. Biochem."},{"key":"1738_CR69","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1055\/s-0035-1559782","volume":"123","author":"M Livingston","year":"2015","unstructured":"M. Livingston, P.J. Twomey, A. Basu, S. Smellie, J.W. Kane, A. Heald, Should free thyroxine go back into the routine thyroid profile? Exp. Clin. Endocrinol. Diabetes 123, 594\u2013597 (2015)","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"1738_CR70","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0140-6736(00)04060-5","volume":"357","author":"CM Dayan","year":"2001","unstructured":"C.M. Dayan, Interpretation of thyroid function tests. Lancet 357, 619\u2013624 (2001)","journal-title":"Lancet"},{"key":"1738_CR71","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0140-6736(00)04248-3","volume":"357","author":"CA Wardle","year":"2001","unstructured":"C.A. Wardle, W.D. Fraser, C.R. Squire, Pitfalls in the use of thyrotropin concentration as a first-line thyroid-function test. Lancet 357, 1013\u20131014 (2001)","journal-title":"Lancet"},{"key":"1738_CR72","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1530\/EJE-09-0328","volume":"161 Suppl 1","author":"M Klose","year":"2009","unstructured":"M. Klose, B. Jonsson, R. Abs, V. Popovic, M. Koltowska-Haggstrom, B. Saller, U. Feldt-Rasmussen, I. Kourides, From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis. Eur. J. Endocrinol. 161 Suppl 1, S75\u2013S83 (2009)","journal-title":"Eur. J. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1738-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1738-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1738-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T01:10:17Z","timestamp":1720573817000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1738-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,6]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1738"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1738-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,6]]},"assertion":[{"value":"10 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}